Page 21 - 113中文衛福年報 有聲書

2024 Taiwan Health and Welfare Report Introduction

and adults who are victims, promptly removes and deletes sexual
另配合強化社會安全網計畫，整
images, offers consultation hotline services, and refers victims to
合保護服務、高風險家庭通報及
appropriate services as needed.
相關服務體系，本部建立集中派
案窗口，優化各項保護服務流程
In addition, in line with the Strengthening Social Safety Net Program,
及時效品質管控機制，串接多樣 the Ministry integrates protection services, high-risk family reporting,
風險資訊，評估兒少、老人與身 and related service systems. It has established a centralized case
心障礙者之保護及風險因子，提 dispatching window to optimize various protection service processes
and ensure timely quality control mechanisms. It connects diverse
供多元處遇服務，依需求積極布
risk information, evaluates the protection and risk factors affecting
建服務資源，增進保護服務品質
children, the elderly, and people with disabilities, and provides
與量能，落實保障被害人及其家
diverse intervention services. Actively deploying service resources
庭之安全與福祉。
according to demand, it enhances the quality and capacity of
protection services to ensure the safety and well-being of victims
and their families.

12 研究發展與

國際合作

Research, Development and
International Cooperation

In 2023, the Ministry of Health and Welfare had 51.5 billion NTD in
112 年度衛生福利科技研究預算約
budget for technological development. It has been spent in three
51.5 億元，分別投入三大面向：任
main areas: 1. task-oriented empirical research, 2. development
務導向型的實證政策研究、創新及
of innovative and translational research and 3. Health and welfare
轉譯研究、衛福資料統計應用。
statistics use.
任務導向的實證研究面向包括民
Task-oriented empirical research includes health promotion for
眾健康促進、食品藥物管理、中
people, food and drug management, Chinese medicine research and
醫藥研發與推廣、原住民族健康
development and promotion, the National Indigenous Peoples Health
研究中心、高齡醫學跨國合作研 Research Center, cross-national cooperation in geriatric medicine, the
究、臺灣精準環境醫學聯盟、傳 Taiwan Alliance for Precision Environmental Medicine, and infectious
染病防治等。 disease prevention and control, among others.

創新及轉譯研究面向包括專利技術 Innovative and interpretation research includes patent technology 11
授權、癌症轉譯研究、腸病毒 71 licensing, cancer translational medicine research, research on the

型疫苗、國家衛生研究院生物製劑 enterovirus 71 vaccine, the Biologics Facility II of the National Health
Research Institutes, and the National Infectious Disease Bank.
二廠及國家感染性疾病資源庫。
12

19